Ronit Capital LLP Nuvectis Pharma, Inc. Transaction History
Ronit Capital LLP
- $74.3 Million
- Q3 2022
A detailed history of Ronit Capital LLP transactions in Nuvectis Pharma, Inc. stock. As of the latest transaction made, Ronit Capital LLP holds 562,547 shares of NVCT stock, worth $4.36 Million. This represents 5.37% of its overall portfolio holdings.
Number of Shares
562,547
Previous 419,282
34.17%
Holding current value
$4.36 Million
Previous $4.7 Million
15.08%
% of portfolio
5.37%
Previous 6.66%
Shares
3 transactions
Others Institutions Holding NVCT
# of Institutions
32Shares Held
1.9MCall Options Held
0Put Options Held
0-
Baldwin Brothers LLC356KShares$2.76 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA325KShares$2.52 Million0.0% of portfolio
-
Marshall Wace, LLP London, X0125KShares$965,4250.0% of portfolio
-
Black Rock Inc. New York, NY83.4KShares$646,4430.0% of portfolio
-
Geode Capital Management, LLC Boston, MA79.2KShares$614,1330.0% of portfolio
About Nuvectis Pharma, Inc.
- Ticker NVCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,642,500
- Market Cap $113M
- Description
- Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...